# Pr3vent

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/pr3vent

- Industry: Medical Devices & Equipment
- Headquarters: Palo Alto, US
- Website: http://www.pr3vent.com
- Latest round: Seed (Oct 16, 2018)
- Investors on record: 2

## About

Pr3vent, Inc. focuses on advanced newborn eye screening, providing high-resolution imaging services to identify potential eye pathologies in infants early in life, ensuring timely referrals for necessary interventions.Pr3vent, Inc., founded in 2017, specializes in advanced eye screening solutions for newborns. The company is headquartered in Palo Alto, US, and has undergone strategic pivots to enhance its offerings. The firm was co-founded by Darius Moshfeghi and Jochen Kumm, the latter also serving as CEO. Pr3vent has successfully completed two funding deals, with the latest being a SERIES A round on February 12, 2019, led by InFocus Capital Partners.Pr3vent specializes in advanced newborn eye screening, offering a high-resolution imaging service designed to identify eye pathologies in infants early in life. The core product, the Advanced Newborn Eye Screen, utilizes a specialized pediatric retina camera to capture detailed images of the retina after the dilation of the baby’s pupils. This comprehensive examination is conducted by retina specialists who analyze the images to detect any vision-threatening conditions, providing crucial referrals to pediatric ophthalmologists as needed. The service primarily targets parents of newborns and pediatric healthcare providers, ensuring early detection and potential intervention for vision-related issues. Currently, Pr3vent operates in several key markets across the United States, focusing on metropolitan areas where access to pediatric health services is critical.Pr3vent generates revenue through direct-to-consumer transactions, allowing parents to schedule the Advanced Newborn Eye Screening for their infants. The company operates on a fee-for-service model, charging for each individual screening performed. This service may be bundled with additional consultations or referrals to specialists, enhancing the overall value provided to clients. Given the significance of early vision screening, Pr3vent's offerings appeal to healthcare providers seeking to integrate advanced screening solutions into their practices. The pricing structure reflects the premium nature of the high-resolution imaging technology and the expertise of the specialists involved in the examination process.Pr3vent plans to utilize the proceeds from its recent SERIES A funding round to enhance its product offerings and expand its market reach. The company is developing new imaging technologies aimed at further improving the accuracy and efficiency of eye screenings. Additionally, Pr3vent is targeting expansions into new metropolitan areas across the United States by late 2022, focusing on regions with limited access to pediatric eye care services. The funding will support these initiatives, ensuring the company can meet the increasing demand for its innovative screening solutions.

## Funding rounds

- Seed, Oct 16, 2018 — Skyview Capital, Trousdale Ventures

## Investors

- Skyview Capital (https://capitalatlas.ai/funds/skyview-capital) — Seed
- Trousdale Ventures (https://capitalatlas.ai/funds/trousdale-ventures) — Seed